Academia.eduAcademia.edu

Outline

Title
Abstract
Introduction
References
All Topics
Sociology

Methodological intimacies and the figure of the twins

Profile image of Florence ChiewFlorence Chiew

2019, The Sociological Review

https://doi.org/10.1177/0038026119831175
visibility

…

description

6 pages

link

1 file

Abstract

In mythology twins represent both dualism and entanglement. Saturated with archetypal meaning, the figure of the twins unsettles divisions between nature and culture and – in its various incarnations as the double, doppelganger, shadow, or fetch – it troubles the notion of a unique, bounded self. This article draws on the indivisible intimacy of twins to examine the anxieties of influence and competition that disrupt claims within the ontological turn about theoretical and methodological innovation. The curious phenomenon of ‘twinning’, we argue, captures a sense of the dangerous intimacy that is operative not only at the level of empirical research on twins but also at the level of intellectual work itself where novelty is often cast in terms of breaking away from imitation to forge an identity that is original and singular. To unpack the burden of competition and originality that underpins concerns about methodological intimacy, we trace a path from ancient mythologies to foundati...

Related papers

The Doppelgänger: Literature’s Philosophy. New York: Fordham University Press, 2010.
Dimitris Vardoulakis
View PDFchevron_right
Entangled Bodies: Rethinking Twins and Double Images in the Prehistoric Mediterranean
Lauren Talalay
View PDFchevron_right
Identity Matters: 'Originals' and 'Copies' in Literary Works Focusing on the Theme of the Double
Michal Tal

This paper addresses the theme of originality and authenticity from the perspective of literary works focusing on the theme of the double (doppelgänger). Literary pieces focusing on this theme present a protagonist who encounters his/her double. This encounter often causes the protagonist(s) to investigate his/her authenticity vis-à-vis the identical other. One tends to see oneself as either the origin or the copy, which has a powerful effect on her self-image and identity. In other words, doppelgänger works seem to powerfully dramatize the cultural tension concerning the definition of identity and the meaning of authenticity. In fact, as I shall try to show, the investigation into authenticity as both a theoretical construct and a personal characteristic seems to be one of the axes around which several major doppelgänger works revolve. This paper will focus on the works of Dostoyevsky, Saramago, and Millás as representatives of this thematic literature.

View PDFchevron_right
'Stir It Up': Contestation and the Dialogue in the Artistic Practice of the Twin of Twins
Abdoulaye Gaye

It is widely accepted in Caribbean studies that there is an ongoing resistance culture in Jamaica's dancehalls. However, the notion of resistance has remained confined to the terrain of what Carolyn Cooper calls 'border clashes' – local versus global, culture versus slackness, uptown versus downtown, and popular culture versus high culture. This article underlines the distinctive creativity of dancehall artistes such as the Twin of Twins, whose artistic practice generates a textual arena where different discourses can interact dialectically in various forms. It primarily explores the Twins' treatment of resistance culture in their represented spaces. It subsequently discusses the dialogic dynamics involved in the relationship between the dominant and dominated classes. These analyses reveal the relational ethos of dancehall DJs' counter-narratives and the Twin of Twins' ability to produce a dialogic relation to social reality.

View PDFchevron_right
Cronenberg, Greenaway and the Ideologies of Twinship
Stephen Weninger

Body & Society, 2003

This article deals with the representation of identical twins in the films Zed and Two Noughts by Peter Greenaway and Dead Ringers by David Cronenberg. It situates the films in a cultural and political context of the 20th-century controversies surrounding the issues of evolution, reproduction and cloning. The article claims that twinship represents the corporeal economy of the Same, whose ideological meanings have been shaped by the history of eugenics and social Darwinism. Identical twinship inscribes a utopia of the perfect, unchanging and self-identical body, opposed to the unpredictability, confusion and contingency of sexual reproduction and evolutionary history. The films under discussion critique the utopian ideology of twinship and its imaginary cancellation of difference as narcissistic and deadly.

View PDFchevron_right
Journal of Dialogue Studies Volume 2 Number 2 Paper 6: ‘Stir It Up’: Contestation and the Dialogue in the Artistic Practice of the Twin of Twins
Dialogue Society

It is widely accepted in Caribbean studies that there is an ongoing resistance culture in Jamaica’s dancehalls. However, the notion of resistance has remained confined to the terrain of what Carolyn Cooper calls ‘border clashes’ – local versus global, culture versus slackness, uptown versus downtown, and popular culture versus high culture. This article underlines the distinctive creativity of dancehall artistes such as the Twin of Twins, whose artistic practice generates a textual arena where different discourses can interact dialectically in various forms. It primarily explores the Twins’ treatment of resistance culture in their represented spaces. It subsequently discusses the dialogic dynamics involved in the relationship between the dominant and dominated classes. These analyses reveal the relational ethos of dancehall DJs’ counter-narratives and the Twin of Twins’ ability to produce a dialogic relation to social reality.

View PDFchevron_right
Twins Talk: What Twins Tell Us about Person, Self, and Society. Dona Lee Davis, Athens: Ohio University Press, 2014, 321 pp
Alison Cool

Medical Anthropology Quarterly, 2015

View PDFchevron_right
Twins, Siblings and Close Neighbours: The Uses of Metaphor and the Genealogy of the Study of Religions - A Response to Kim Knott
romli Atmasasmita

Temenos - Nordic Journal of Comparative Religion, 2008

View PDFchevron_right
"Doubles and doppelgangers : religious meaning for the young and old"
Philippe St-Germain
View PDFchevron_right
Doubled Self and the Workship of the Gods
Charles Stang

Maren R. Niehoff and Joshua Levinson (eds), Constructions of the Self in the Roman Empire (Mohr Siebeck, 2020), pp. 149-168, 2020

View PDFchevron_right

References (68)

  1. McFaline-Figueroa JR, Lee EQ. Brain Tumors: Am J Med 2018; pii: S0002-9343(18)30031-7.
  2. Pearson JRD, Regad T: Targeting cellular pathways in glio- blastomamultiforme. Signal Transduct Target Ther 2017; 2:17040.
  3. Ohgaki H, Kleihues P: The definition of primary and secon- dary glioblastoma. Clin Cancer Res 2013; 19(4):764-72.
  4. Wilson TA, Karajannis MA, Harter DH: Glioblastomamul- tiforme: State of the art and future therapeutics. Sur- gNeurolInt 2014; 5:64.
  5. Cohen AL, Holmen SL, Colman H: IDH1 and IDH2 muta-tions in gliomas. CurrNeurolNeurosci Rep 2013;13(5):345.
  6. Ohgaki H, Kleihues P: Genetic pathways to primary and secondary glioblastoma. Am J Pathol 2007; 170(5):1445-53.
  7. Szala S, Jarosz M, Smolarczyk R, et al: ["Vicious circles" of glioblastoma tumors: vascularization and invasiveness].
  8. PostepyHig Med Dosw (Online) 2012; 66:888-900.
  9. Walecki J., Chojnacka E: Imaging diagnostic of brain tu-mors. Par t I -neuroepithelial tumors. Onkol. Prakt. Klin 2007; 3:178-179.
  10. Clarke J, Butowski N, Chang S: Recent advances in the-rapy for glioblastoma. Arch Neurol 2010; 67:279-83.
  11. Stupp R, Hegi ME, van den Bent MJ, et al: Changing paradigms-an update on the multidisciplinary manage-ment of malignant glioma. Oncologist 2006; 11:165-80.
  12. Zawlik I., Vaccarella S., Kita D., et al: Promoter methyla-tion and polymorphisms of the MGMT gene in gliobla-stomas: a population-based study. Neuroepidemiology 2009; 32: 21- 29.
  13. Hegi ME, Diserens AC, Gorlia T, et al: MGMT gene silen-cing and benefit from temozolomide in glioblastoma. N Engl J Med 2005; 352(10):997-1003.
  14. Rivera AL, Pelloski CE, Gilbert MR, et al: MGMT promoter methylation is predictive of response to radiothera-py and prognostic in the absence of adjuvant alkyla-ting chemotherapy for glioblastoma. NeuroOncol 2010; 12(2):116- 21.
  15. Brat DJ, Van Meir EG: Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma. Lab Invest 2004; 84: 397-405.
  16. Nishikawa R, Sugiyama T, Narita Y, et al: Immunohistochemi-cal analysis of the mutant epidermal growth factor, deltaEGFR, in glioblastoma. Brain Tumor Pathol 2004; 21: 53-56.
  17. Sharma S, Sharma MC, Gupta DK, et al: Angiogenic patterns and their quantitation in high grade astrocytic tumors. JNeurooncol 2006; 79: 19-30.
  18. Wang R, Chadalavada K, Wilshire J, et al:Glioblastoma stem- like cells give rise to tumour endothelium. Natu-re 2010; 468:829-33.
  19. Soda Y, Marumoto T, Friedmann-Morvinski D, et al. Trans- differentiation of glioblastoma cells into vascular endo-thelial cells. ProcNatlAcadSci U S A 2011; 108:4274-80.
  20. Cheng L, Huang Z, Zhou W, et al:Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth Cell. 2013; 153:139-52.
  21. Griffioen AW, Molema G: Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases and chronic Inflammation. Phar- macol Reviews 2000; 52: 237-268.
  22. Thompson WD, Shiach KJ, Fraser RA, et al: Tumors aqu-ire their vasculature by vessel incorporation, not vessel in- growth. JPathol 1987; 151: 323-332.
  23. Kurzyk A: [Angiogenesis -possibilities, problems and perspectives]. PostepyBiochem 2015; 61(1):25-34.
  24. Shibuya M: Structure and function of VEGF/VEGF-recep-tor system involved in angiogenesis. Cell StructFunct 2001; 26: 25-35.
  25. Diaz RJ, Ali S, Qadir MG, De La Fuente MI, et al: The ro-le of bevacizumab in the treatment of glioblastoma. J Neurooncol 2017; 133(3):455-467.
  26. Friedman HS, Prados MD, Wen PY, et al: Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblasto-ma. J ClinOncol. 2009; 27(28):4733-40.
  27. Kreisl TN, Kim L, Moore K, Duic P et al: Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblasto-ma. J ClinOncol 2009; 27(5):740-745.
  28. Chamberlain MC, Johnston S: Salvage therapy with sin-gle agent bevacizumab for recurrent glioblastoma. JNeu-rooncol 2010; 96(2):259-69.
  29. Raizer JJ, Grimm S, Rice L, et al: A phase II trial of single- agent bevacizumab given every 3 weeks for recurrent malignant gliomas [abstract].
  30. J ClinOncol. 2009;27(Suppl 15):98s. Abstract 2044.
  31. Jain RK: Normalizing tumor vasculature with anti-angio- genic therapy: a new paradigm for combination therapy. Nat. Med 2001;7: 987-989.
  32. Gilbert MR, Dignam JJ, Armstrong TS, et al: A randomi-zed trial of bevacizumab for newly diagnosed glioblasto-ma N Engl J Med 2014; 370(8):699-708.
  33. Chinot OL, Wick W, Mason W,et al: Bevacizumab plus radiotherapy-temozolomide for newly diagnosed gliobla- stoma. N Engl J Med 2014; 370(8):709-722.
  34. Herrlinger U, Schäfer N, Steinbach JP: The randomized, mul- ticenter GLARIUS trial investigating bevacizumab/irinotecanvs standard Temozolomide in newly diagnosed, MGMT-non- methylated glioblastomapatients: Final survival results and quality of life. NeuroOncol 2014; 16(Suppl 2): ii23-ii24.
  35. Gorski DH, Beckett MA, Jaskowiak NT, et al:Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Res 1999; 59(14):3374-8.
  36. Geng L, Donnelly E, McMahon G, et al: Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy. Cancer Res 2001; 61: 2413-2419.
  37. Gutin PH, Iwamoto FM, Beal K, et al: Safety and efficacy of bevacizumab with hypofractionated stereotactic irra-diation for recurrent malignant gliomas. Int J RadiatOn-colBiolPhys 2009; 75(1):156-63.
  38. Taal W, Oosterkamp HM, Walenkamp AM, et al: Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled pha-se 2 trial. Lancet Oncol 2014; 15(9):943-53.
  39. Wick W, Brandes AA, Gorlia T, et al: EORTC 26101 phase III trial exploring the combination of bevacizumab and lomustine in patients with first progression of a gliobla-stoma. J ClinOncol 2016; 34(suppl) abstract 2001.
  40. Taal W, Oosterkamp HM, Walenkamp AM, Dubbink HJ, et al: Single-agent bevacizumab or lomustine versus a com- bination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised con- trolled phase 2 trial. Lancet Oncol 2014; 15(9):943-953.
  41. Nagpal S, Harsh G, Recht L: Bevacizumab improves quali-ty of life in patients with recurrent glioblastoma. Chemo-ther Res Pract 2011; 2011:602812.
  42. Odia Y, Sul J, Shih JH, et al: A Phase II trial of tanduti-nib (MLN 518) in combination with bevacizumab for patients with recurrent glioblastoma. CNS Oncol 2016; 5(2):59-67.
  43. Rubenstein JL, Kim J, Ozawa T, et al: Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption. Neoplasia 2000; 2(4):306-14.
  44. Kunkel P, Ulbricht U, Bohlen P, et al.: Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2. Cancer Res 2001; 61(18):6624-8.
  45. Iwamoto FM, Lamborn KR, Robins HI, et al: Phase II trial of pazopanib (GW786034), an oral multi-targeted angio-genesis inhibitor, for adults with recurrent glioblasto-ma (North American Brain Tumor Consortium Study 06-02). NeuroOncol 2010; 12(8):855-861.
  46. Rundhaug JE: Matrix metalloproteinases and angiogene- sis. J Cell Mol Med 2005; 9: 267-285.
  47. © Oncology and Radiotherapy 2 (44) 2018: 017-022
  48. Kreisl TN, Smith P, Sul J, et al: Continuous daily sunitinib for recurrerntglioblastoma. J Neurooncol 2013; 111(1):41-8.
  49. de Bouard S, Herlin P, Christensen JG, et al: Antiangio-genic and anti-invasive effects of sunitinib on experimen-tal human glioblastoma. NeuroOncol 2007; 9(4):412-423.
  50. Neyns B, Sadones J, Chaskis C, et al: Phase II study of sunitinib malate in patients with recurrent high-grade glioma. J Neurooncol 2011; 103(3):491-501.
  51. Balańa C, Gil MJ, Perez P, et al: Sunitinib administered prior to radiotherapy in patients with non-resectable glio-blastoma: results of a phase II study. Target Oncol 2014; 9(4):321-9.
  52. Iwamoto FM, Lamborn KR, Robins HI, et al: Phase II trial of pazopanib (GW786034), an oral multi-targeted angio-genesis inhibitor, for adults with recurrent glioblasto-ma (North American Brain Tumor Consortium Study 06-02). NeuroOncol 2010; 12(8):855-861.
  53. Reardon DA, Groves MD, Wen PY, et al: A phase I/II trial of pazopanib in combination with lapatinib in adult pa-tients with relapsed malignant glioma. Clin Cancer Res 2013; 19(4):900- 8.
  54. Desjardins A, Quinn JA, Vredenburgh JJ, et al: Phase II study of imatinibmesylate and hydroxyurea for recurrent grade III malignant gliomas. J Neurooncol 2007; 83:53-60.
  55. Raymond E, Brandes AA, Dittrich C: Phase II study of imatinib in patients with recurrent gliomas of various histologies: a European Organisation for Research and Treatment of Cancer Brain Tumor Group Study. J ClinOn-col 2008; 26:4659-4665.
  56. Batchelor TT, Duda DG, di Tomaso E, et al: Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma. J ClinOncol 2010; 28:2817-2823.
  57. Batchelor TT, Sorensen AG, di Tomaso E, et al: AZD2171,a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumorvasculature and alleviates edema in glioblastoma patients. Cancer Cell 2007; 11: 83-95.
  58. Batchelor TT, Mulholland P, Neyns B, et al: Phase III ran- domized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma. J ClinOncol 2013; 31(26):3212-8.
  59. Gasparini G, Longo R, Toi M: Angiogenic inhibitors: a newtherapeutic strategy in oncology. Nat ClinPractOncol 2005; 2, 562-577.
  60. Nabors LB, Fink KL, Mikkelsen T, et al: Two cilengitide regi- mens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT genepromoter: results of the open-label, controlled, rando- mized phase II COREstudy. NeuroOncol 2015; 17, 708-717.
  61. Stupp R, Hegi ME, Neyns B, et al: Phase I/IIa study of cilengitide and temozolomide with concomitant radiothe-rapy followed by cilengitide and temozolomide mainte-nance therapy in patients with newly diagnosed gliobla-stoma. J ClinOncol 2010; 28(16):2712-2718.
  62. Stupp R, Hegi ME, Gorlia T, et al: Cilengitide combined with standard treatment for patients with newlydiagnosedglio- blastoma with methylated MGMT promoter (CENTRIC EORTC26071-22072 study): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol 2014; 15, 1100-1108.
  63. Hau P, Jachimczak P, Schlingensiepen R, et al: Inhibition of TGF-beta2 with AP 12009 in recurrent malignant glio-mas: from preclinical to phase I/II studies. Oligonucleoti-des 2007; 17: 201-212.
  64. Bogdahn U, Hau P, Stockhammer G, et al: Targeted the-rapy for high-grade glioma with the TGF-â2 inhibitor trabedersen: results of a randomized and controlled phase IIb study. NeuroOncol 2011; 13(1):132-42.
  65. Chang SM, Wen P, Cloughesy T, et al: Phase II study of CCI- 779 in patients with recurrent glioblastomamultifor-me. Invest New Ugs 2005; 23: 357-361.
  66. Galanis E, Buckner JC, Maurer MJ, et al: Phase II trial of temsirolimus (CCI-779) in recurrent glioblastomamultifor-me: a North Central Cancer Treatment Group Study. J ClinOncol 2005; 23: 5294-5304.
  67. Sarkaria JN, Galanis E, Wu W, et al: Combination of tem- sirolimus (CCI-779) with chemoradiation in newly diagno-sed glioblastomamultiforme (GBM) (NCCTG trial N027D) is associated with increased infectious risks. Clin Cancer Res 2010; 16:5573-80.
  68. Wick W, Gorlia T, Bady P, et al: Phase II Study of Radio- therapy and Temsirolimus versus Radiochemotherapy with Temozolomide in Patients with Newly Diagnosed Gliobla- stoma without MGMT Promoter Hypermethylation (EORTC 26082). ClinCancer Res 2016; 22(19):4797-4806.

Related papers

Methodological Intimacy and the Figure of the Twins (Chiew and Barnwell, 2019)
Florence Chiew

The Sociological Review, 2019

In mythology twins represent both dualism and entanglement. Saturated with archetypal meaning, the figure of the twins unsettles divisions between nature and culture and-in its various incarnations as the double, doppelganger, shadow, or fetch-it troubles the notion of a unique, bounded self. This paper draws on the indivisible intimacy of twins to examine the anxieties of influence and competition that disrupt claims within the ontological turn about theoretical and methodological innovation. The curious phenomenon of 'twinning', we argue, captures a sense of the dangerous intimacy that is operative not only at the level of empirical research on twins but also at the level of intellectual work itself where novelty is often cast in terms of breaking away from imitation to forge an identity that is original and singular. To unpack the burden of competition and originality that underpin concerns about methodological intimacy, we trace a path from ancient mythologies to foundational research in twinship. In exploring the tension between hardwired dis/similarity and entanglement through the potent figure of the twins, this paper considers how we might address methodological questions about identity and intimacy within the ontological turn.

View PDFchevron_right
Twinship in mythology and science: Ambivalence, differentiation, and the magical bond
Benjamin Beit-Hallahmi

Comprehensive Psychiatry, 1974

View PDFchevron_right
The Archetype of the Twins in Literature
Tamar Mebuke

PHASIS, 2005

The aim of the paper is to study the works of fiction, depicting the theme of a double and to find the archetype that stands behind it. The theme of a double has been widely used in literature by numerous authors with different interpretation that indicates an archetype which finds different manifestation in different cases. The theme is often associated with the quest of a self for origins, identity and unity. Such spheres compose the realm of human soul and relate to those fundamental notions of psychology, which K.G.Young named archetypes. An archetype indicates former images, ancient infinity of images, the ancient means of the Universe. The deeper layers of soul lose their individual non-repeatability, in proportion to the degree to which they increasingly further and further step back into the gloom. Descending increasingly below and approaching a level of the autonomously functioning systems, they acquire even more collective and more universal nature, until they fade in the material substances. Consequently, on the bottom itself "soul" is simply the Universe 1. It is in the inner sense, standing behind these archetypes (images of archetype) that we should search for the source of the archetypes of human behavior and the source of subjects in fiction, describing this behavior. It seems natural to look for the source of the archetype of the double in the myths about twins, as the main source of archetypes are myths that preserve and transfer paradigms-images in the imitation of which the entire totality of actions, for which man takes responsibility upon himself, are achieved 2 .

View PDFchevron_right
Ode in Onia: Reading the Use of Myth and Twinhood in Diana Evans’ 26a
Dr Afan Azhang Kazé

Journal of English Language and Literature, 2017

Postcolonial writers have over time engaged in the use of folklore preserved from their precolonial heritage in their works that try to understand the complexities of their postcolonial existence. Such writers have used ancient stories, songs, proverbs and other ideas from their vernacular cosmologies in intertextual conversation with their fiction. In this article, I discuss this kind of practice in the novel 26a by Nigerian-British novelist, Diana Evans. The novel explores personal experiences of twinhood which also raises questions about identity, transnationalism and migration. This paper's focus is on the ways in which Evans fetches material from her Nigerian backgroundthe myth about twinhoodand merges it with her fiction, allowing both to engage and transform each other. Through this she has not only created a work of magical realism, but finds an effective means to represent trauma, psychic and existential struggles along with what it means to exist between categories.

View PDFchevron_right
Embodying “ twoness in oneness ” in
Irene Pérez Fernández

2016

Diana Evans’ debut novel 26a deals with the parallel childhood and subsequent dissimilar adult development of a set of female identical twins. Identical twins problematize the definition of identity and individuality by their superfluity, since being an identical twin is paradoxical, in that that one’s body is a signifier of both individuality and twoness or duality. This article investigates the space of individual identity. Focusing on the body as the primary space of interaction, it analyzes the problematics inherent to a relation of twinship in Nigerian and western tradition, and the significance of the trope of twins in Evans’ narrative, where it functions as a way of negotiating an ethnically diverse identity. The idea of space is important in the construction of the twins’ identities; physical dislocation and dissimilar experiences bring about identity crises, and eventually death for one of the twins.

View PDFchevron_right

Related topics

  • Sociology
    • 580 California St., Suite 400
    San Francisco, CA, 94104
    © 2025 Academia. All rights reserved